Precision BioSciences
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $18 | $29 | $638 | $576 |
Gross Profit | -678 | 29 | 638 | 576 |
EBITDA | -22,466 | -19,506 | -16,596 | -15,158 |
EBIT | -23,162 | -20,211 | -17,353 | -16,169 |
Net Income | -23,520 | -20,565 | -17,745 | -16,425 |
Net Change In Cash | 18 | 29 | 638 | 576 |
Free Cash Flow | -20,273 | -19,116 | -18,780 | -5,951 |
Cash | 62,242 | 77,223 | 85,899 | 98,752 |
Basic Shares | 11,046 | 929,206 | 6,883 | 7,287 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $68,696 | $48,727 | $25,098 | $115,529 |
Gross Profit | 68,696 | 40,472 | 16,094 | 115,529 |
EBITDA | 13,526 | -32,042 | -62,794 | -20,273 |
EBIT | 8,949 | -40,297 | -71,798 | -30,470 |
Net Income | 7,167 | -61,319 | -122,908 | -30,918 |
Net Change In Cash | 68,696 | 48,727 | 25,098 | 115,529 |
Cost of Revenue | 45,913 | 53,865 | ||
Free Cash Flow | -58,695 | -86,392 | -49,072 | -16,656 |
Cash | 85,899 | 116,678 | 189,576 | 143,663 |
Basic Shares | 6,883 | 3,841 | 2,929 | 1,956 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$2.13 |
2025-03-31 | -$2.21 |
2024-12-31 | -$2.13 |
2024-09-30 | -$2.25 |
